U.S. Communications Stock News

CG Oncology, Inc. reported past full-year 2025 results, with revenue rising to US$4.04 million from US$1.14 million and net loss widening to US$161 million from US$88.04 million, alongside confirmation that its leadership presented at the TD Cowen 46th Annual Health Care Conference earlier this month. The combination of higher revenue with a larger loss highlights the company’s ongoing investment in its business model and cost structure, which investors may weigh against its early-stage...

Recent results put Viatris's profitability under the microscope Viatris (VTRS) has just posted its FY 2025 numbers, with fourth quarter revenue of US$3,703.6 million and a basic EPS loss of US$0.30, while trailing twelve month revenue came in at US$14.3 billion alongside a basic EPS loss of US$3.00. Over recent periods, the company has seen quarterly revenue move from US$3,528.1 million in Q4 2024 to US$3,703.6 million in Q4 2025, with basic EPS shifting from a loss of US$0.43 to a loss of...

Rocket Companies FY 2025 Results: Revenue Rebound but Profitability Still Tight Rocket Companies (RKT) has just posted its FY 2025 numbers with Q4 revenue of US$2.8 billion and basic EPS of US$0.02, setting a very different tone from earlier quarters in the year that were in loss territory. The company has seen quarterly revenue move from US$1.1 billion in Q1 2025 to US$1.7 billion in Q3 and then to US$2.8 billion in Q4. EPS shifted from losses of US$0.07 in Q1 and US$0.06 in Q3 to a small...

PAR Technology (PAR) closed out FY 2025 with Q4 revenue of US$120.1 million and a basic EPS loss of US$0.51, while trailing twelve month revenue sat at US$455.5 million alongside a basic EPS loss of US$2.09. Over recent quarters, the company has seen revenue move from US$96.8 million in Q3 2024 to US$105.0 million in Q4 2024, then to US$103.9 million in Q1 2025, US$112.4 million in Q2 2025, US$119.2 million in Q3 2025 and US$120.1 million in Q4 2025, as quarterly basic EPS losses ranged...

In February 2026, Amer Sports reported past fourth-quarter 2025 results showing higher sales and net income year on year, while issuing first-quarter 2026 guidance calling for reported revenue growth of 22%–24% with fully diluted EPS of US$0.28–US$0.30 and full-year 2026 revenue growth of 16%–18% with EPS of US$1.10–US$1.15. Management highlighted that this outlook reflects both the current momentum of Arc’teryx and Salomon and an intention to increase spending on these brands, which may...

Definitive Healthcare (DH) has wrapped up FY 2025 with Q4 revenue of US$61.5 million and a basic EPS loss of US$0.09, alongside a trailing twelve month loss of US$1.30 per share on US$241.5 million of revenue. Over recent periods, the company has reported quarterly revenue between US$59.2 million and US$62.7 million, while basic EPS has ranged from a loss of US$0.07 to a loss of US$1.12. For investors, the latest results keep attention on when margins might begin to close the gap between a...

MasTec (MTZ) has wrapped up FY 2025 with fourth quarter revenue of US$3.9b, basic EPS of US$1.83 and net income excluding extraordinary items of US$142.7m, capping a year in which trailing twelve month revenue reached US$14.3b, EPS came in at US$5.12 and net income was US$399m. Over the past six reported quarters, revenue has ranged from US$2.8b in Q1 2025 to US$4.0b in Q3 2025, while quarterly basic EPS moved between US$0.13 and US$2.07, giving investors a clearer view of how the earnings...

NCR Atleos (NATL) just wrapped up FY 2025 with Q4 revenue of US$1.2b and basic EPS of US$1.13, alongside net income of US$83 million. The trailing twelve month line shows total revenue of US$4.4b and basic EPS of US$2.20. The company has seen quarterly revenue move from US$979 million in Q1 2025 to US$1.2b in Q4 2025, with basic EPS over those quarters ranging from US$0.21 to US$1.13. Trailing twelve month basic EPS shifted from US$1.26 in Q4 2024 to US$2.20 in Q4 2025. Together, these...

In February 2026, Indivior Pharmaceuticals, Inc. reported fourth-quarter 2025 sales of US$358 million and net income of US$102 million, alongside full-year 2025 sales of US$2.48 billion and net income of US$420 million, while reaffirming its 2026 net revenue outlook of US$1.13 billion to US$1.20 billion. The company also highlighted record SUBLOCADE net revenue growth and approved a new US$400 million share repurchase program, underscoring its focus on improving profitability, cash...

Mid-America Apartment Communities recently issued US$200,000,000 of 4.650% senior unsecured notes due 2033 and outlined plans to allocate proceeds toward repaying commercial paper borrowings and funding potential acquisitions, development, and redevelopment projects, while also preparing to discuss its outlook at the 2026 Citi Global Property CEO Conference. Alongside this new debt issuance, management’s increased capital spending plans and active US$932.00 million development pipeline...

If you are wondering whether Bio-Rad Laboratories is offering good value at around US$278.44 per share, this article walks through what the current price might be implying about the business. The stock has had a mixed run, with a 2.6% gain over the last 7 days, a 7.1% decline over 30 days, an 8.8% decline year to date, a 5.0% return over 1 year, a 44.6% decline over 3 years, and a 51.0% decline over 5 years. These ups and downs have kept valuation in focus for many investors, especially as...

Arrowhead Pharmaceuticals recently highlighted its participation in multiple March 2026 healthcare conferences, including TD Cowen, Leerink, Jefferies, and Barclays, featuring fireside chats and investor meetings with materials available via its investor relations website. Alongside this conference schedule, the company’s RNAi pipeline progress, including two Phase 3 candidates supported by major pharma collaborations, has drawn heightened analyst attention and optimism about its development...

Plains GP Holdings (PAGP) just reported its 2025 results, with Q4 adjusted EBITDA of $738 million and full year EBITDA of $2.833 billion, while outlining a shift toward a focused crude oil midstream business. See our latest analysis for Plains GP Holdings. The latest results and portfolio reshaping come after a strong run in the units, with a 30 day share price return of 8.05% and a 90 day share price return of 21.57%. The 5 year total shareholder return of 230.28% points to momentum that has...

Floor & Decor Holdings (FND) is back on investors’ radar after opening new warehouse-format stores and design centers in Fayetteville, Vacaville, and Staten Island, extending its footprint and community presence. See our latest analysis for Floor & Decor Holdings. The recent store openings and 2026 guidance have arrived during a mixed period for investors, with the 90 day share price return of 8.6% and year to date share price return of 9.72% contrasting with a 1 year total shareholder return...

Hamilton Lane recently led a US$500 million growth equity investment in VFN Holdings to expand its U.S. fiber network capabilities and support mergers and acquisitions, with Hamilton Lane executives joining VFN’s board to provide guidance. This move highlights Hamilton Lane’s focus on private equity and growth capital in infrastructure-like, innovation-oriented sectors that could reshape digital connectivity in the United States. We’ll now examine how leading this sizeable VFN Holdings...

Argan, Inc. recently announced two major contract wins in Texas to build a 1,350 megawatt combined-cycle power plant and an 860 megawatt natural gas-fired power plant aimed at serving electricity demand from AI-focused data centers. These wins underscore how Argan’s engineering and construction expertise is becoming increasingly relevant as power infrastructure expands to support energy-hungry AI data centers. Next, we’ll explore how these new Texas power plant contracts could reshape...

In recent days, Vir Biotechnology announced a global collaboration with Astellas Pharma to co-develop and co-commercialize VIR-5500 for prostate cancer, alongside completing a US$150,000,002 follow-on equity offering of 17,647,059 common shares at US$8.50 each. This combination of a large upfront and near-term payment package from Astellas and fresh equity capital materially reshapes Vir’s funding profile and partnership mix. We’ll now examine how this Astellas collaboration and capital...

Dean Kamen has resigned from BETA Technologies’ (NYSE:BETA) Board of Directors following questions about his past associations. Kamen stepped down to avoid potential distractions for the company as scrutiny of his previous dealings with Jeffrey Epstein increased. The resignation draws attention to BETA Technologies’ board composition and broader governance practices at a time when investors are closely watching leadership and oversight. BETA Technologies, traded as NYSE:BETA, focuses on...

MP Materials has reported fourth-quarter 2025 sales of US$52.69 million and net income of US$9.43 million, while simultaneously committing more than US$1.25 billion to build its 10X rare earth magnet manufacturing campus on a 120-acre site in Northlake, Texas, backed by roughly US$200 million in long-term state and local incentives. The 10X project, underpinned by a 10-year Pentagon offtake commitment and reinforced by MP’s fully integrated mining-to-magnet platform and recycling loops, is...

Chesapeake Utilities (CPK) has wrapped up FY 2025 with fourth quarter revenue of US$258.9 million and basic EPS of US$1.94, alongside full year trailing twelve month revenue of US$930 million and EPS of US$6.00. Over recent periods, the company has seen quarterly revenue move from US$215.0 million and EPS of US$1.60 in Q4 2024 to US$298.7 million and EPS of US$2.22 in Q1 2025, before landing at the latest Q4 2025 figures, with trailing net income reaching US$140.3 million. With earnings...

CarGurus (CARG) is back in focus after reporting Q4 and full year 2025 results, issuing 2026 revenue guidance, and outlining fresh share repurchase activity that together give investors new information to assess the stock. See our latest analysis for CarGurus. Despite the fresh earnings, guidance and new buyback authorization, recent share price performance has been soft, with a 30 day share price return of 8.08% and a year to date share price return of 18.41%. At the same time, the 3 year...

Vipshop Holdings (NYSE:VIPS) closed out FY 2025 with fourth quarter revenue of C¥32.5b and basic EPS of C¥5.29, while trailing 12 month revenue stood at C¥105.9b and EPS at C¥14.47. Over the last six reported quarters, the company has seen quarterly revenue range from C¥20.7b to C¥33.2b alongside basic EPS between C¥2.00 and C¥5.29. This gives you a clear view of how top line scale and per share profitability have moved together into this latest print. Taken together with a net margin last...

C.H. Robinson Worldwide (NasdaqGS:CHRW) is rolling out its Lean AI program, aiming to reshape its core freight brokerage and logistics workflows. The company is selling non core assets and sharpening its focus on AI powered logistics tools and digital platforms. C.H. Robinson is also building out cross border capabilities to align with nearshoring trends and evolving customer supply chain needs. C.H. Robinson enters this phase of change with its shares at $185.18 and recent returns that...

If you are wondering whether Star Bulk Carriers is still reasonably priced after its recent run, you are not alone. This article is here to unpack that question clearly. The stock last closed at US$26.29, with returns of 4.2% over 7 days, 16.1% over 30 days, 35.7% year to date and 71.1% over 1 year, which naturally raises questions about how much value is already reflected in the price. Recent coverage has focused on Star Bulk Carriers as a way for investors to get exposure to the dry bulk...